Vanitha Ramakrishnan
- Physiology top 0.5%
- Hematology top 1%
- Platelet Disorders and Treatments 10
- Blood Coagulation and Thrombosis Mechanisms 7
- Internal Medicine top 2%
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 9
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 6
-
- Monoclonal and Polyclonal Antibodies Research 7
-
- HER2/EGFR in Cancer Research 6
-
- Angiogenesis and VEGF in Cancer 4
-
- Antiplatelet Therapy and Cardiovascular Diseases 3
Vanitha Ramakrishnan
31 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Physiology 446
- Hematology 899
- Internal Medicine 201
- Immunology and Allergy 282
- Genetics 332
Countries citing papers authored by Vanitha Ramakrishnan
This map shows the geographic impact of Vanitha Ramakrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanitha Ramakrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanitha Ramakrishnan more than expected).
Fields of papers citing papers by Vanitha Ramakrishnan
This network shows the impact of papers produced by Vanitha Ramakrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanitha Ramakrishnan. The network helps show where Vanitha Ramakrishnan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vanitha Ramakrishnan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 11 | |
| 2 | 2021 | 23 | |
| 3 | 2014 | 61 | |
| 4 | 2014 | 150 | |
| 5 | 2011 | 12 | |
| 6 | 2010 | 62 | |
| 7 | 2010 | 60 | |
| 8 | 2008 | 303 | |
| 9 | 2007 | 44 | |
| 10 | 2007 | 66 | |
| 11 | Identification of the platelet ADP receptor targeted by antithrombotic drugsbreakdown → | 2001 | 1116 |
| 12 | 2000 | 43 | |
| 13 | 1999 | 74 | |
| 14 | 1999 | 5 | |
| 15 | 1999 | 68 | |
| 16 | 1998 | 5 | |
| 17 | 1997 | 46 | |
| 18 | 1996 | 313 | |
| 19 | 1993 | 9 | |
| 20 | 1987 | 15 |
About Vanitha Ramakrishnan
Vanitha Ramakrishnan is a scholar working on Immunology and Allergy, Hematology and Genetics, having authored 32 papers that have together received 2.8k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (10 papers), Cell Adhesion Molecules Research (9 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), HER2/EGFR in Cancer Research (6 papers), Angiogenesis and VEGF in Cancer (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (3 papers). The work is most often cited by research in Physiology (446 citations), Hematology (899 citations) and Internal Medicine (201 citations). Vanitha Ramakrishnan has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Sverker Nystedt, Johan Sundelin, Paquita Nurden, Alan T. Nurden, David Julius, Gunther Hollopeter, Pamela B. Conley, D Vincent, Laura England and Hans‐Michael Jantzen. Their work appears in journals such as Blood, Journal of Clinical Oncology, Molecular Cancer Therapeutics, Clinical Cancer Research and Growth Factors.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.